The Food and Drug Administration (FDA) announced Sunday that it has authorized convalescent plasma for emergency use to treat patients sickened by the novel coronavirus.
FDA authorizes COVID-19 plasma treatment amid Trump pressure
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over